Sabra Capital Expenditures from 2010 to 2024

SBRA Stock  USD 18.52  0.11  0.60%   
Sabra Healthcare's Capital Expenditures is decreasing over the years with slightly volatile fluctuation. Capital Expenditures is expected to dwindle to about 5 M. From 2010 to 2024 Sabra Healthcare Capital Expenditures quarterly data regression line had arithmetic mean of  183,436,617 and r-squared of  0.11. View All Fundamentals
 
Capital Expenditures  
First Reported
2010-12-31
Previous Quarter
0.0
Current Value
0.0
Quarterly Volatility
108.6 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Sabra Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sabra Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 116.9 M, Interest Expense of 83.2 M or Selling General Administrative of 29.5 M, as well as many indicators such as Price To Sales Ratio of 10.02, Dividend Yield of 0.0653 or PTB Ratio of 1.53. Sabra financial statements analysis is a perfect complement when working with Sabra Healthcare Valuation or Volatility modules.
  
Check out the analysis of Sabra Healthcare Correlation against competitors.

Latest Sabra Healthcare's Capital Expenditures Growth Pattern

Below is the plot of the Capital Expenditures of Sabra Healthcare REIT over the last few years. Capital Expenditures are funds used by Sabra Healthcare REIT to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Sabra Healthcare operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software. It is Sabra Healthcare's Capital Expenditures historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sabra Healthcare's overall financial position and show how it may be relating to other accounts over time.
Capital Expenditures10 Years Trend
Slightly volatile
   Capital Expenditures   
       Timeline  

Sabra Capital Expenditures Regression Statistics

Arithmetic Mean183,436,617
Geometric Mean0.00
Coefficient Of Variation109.42
Mean Deviation144,054,040
Median124,511,000
Standard Deviation200,722,894
Sample Variance40289.7T
Range745.7M
R-Value(0.32)
Mean Square Error38821.3T
R-Squared0.11
Significance0.24
Slope(14,562,469)
Total Sum of Squares564055.5T

Sabra Capital Expenditures History

2024M
20235.2 M
2022146.7 M
202133.6 M
2020105.6 M
2019252.5 M
201893.4 M

About Sabra Healthcare Financial Statements

Sabra Healthcare stakeholders use historical fundamental indicators, such as Sabra Healthcare's Capital Expenditures, to determine how well the company is positioned to perform in the future. Although Sabra Healthcare investors may analyze each financial statement separately, they are all interrelated. For example, changes in Sabra Healthcare's assets and liabilities are reflected in the revenues and expenses on Sabra Healthcare's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Sabra Healthcare REIT. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Capital Expenditures5.2 MM

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Sabra Healthcare REIT offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sabra Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sabra Healthcare Reit Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sabra Healthcare Reit Stock:
Check out the analysis of Sabra Healthcare Correlation against competitors.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sabra Healthcare. If investors know Sabra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sabra Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.111
Dividend Share
1.2
Earnings Share
0.41
Revenue Per Share
2.943
Quarterly Revenue Growth
0.107
The market value of Sabra Healthcare REIT is measured differently than its book value, which is the value of Sabra that is recorded on the company's balance sheet. Investors also form their own opinion of Sabra Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Sabra Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sabra Healthcare's market value can be influenced by many factors that don't directly affect Sabra Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sabra Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sabra Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sabra Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.